These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4151909)

  • 1. Antagonism of cardiac arrhythmias by dl-1-(2-acetyl-4-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane (M & B 17,803A), a new beta adrenoreceptor blocking agent.
    Laddu AR
    Jpn Heart J; 1974 Jan; 15(1):61-71. PubMed ID: 4151909
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular effects of dl-1-(2-acetyl-4-butyramido-phenoxy)-2-hydroxy-3-isopropylaminopropane (M & B 17,803A), a new cardioselective beta adrenoreceptor blocking agent.
    Laddu AR
    Jpn Heart J; 1974 Jan; 15(1):72-83. PubMed ID: 4151910
    [No Abstract]   [Full Text] [Related]  

  • 3. The selective beta receptor blocking properties of DL-1-(2-acetyl-4-n-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane HC1 (M & B 17803-A) in the anesthetized dog.
    Levy B
    J Pharmacol Exp Ther; 1973 Jul; 186(1):134-44. PubMed ID: 4146701
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A.
    Basil B; Jordan R; Loveless AH; Maxwell DR
    Br J Pharmacol; 1973 Jun; 48(2):198-211. PubMed ID: 4147427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic activity of 1-(di-2,6-xylylmethoxy)-3-(isopropylamino) propanol-2-hydrochloride (BS-7977-d) in the dog heart lung preparation.
    Laddu R
    Eur J Pharmacol; 1970 Feb; 9(2):129-35. PubMed ID: 4392344
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of selective beta-adrenoceptor blockade in man.
    Briant RH; Dollery CT; Fenyvesi T; George CF
    Br J Pharmacol; 1973 Sep; 49(1):106-14. PubMed ID: 4150760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of pretreatment with pronethalol on the toxicity of strospeside in the dog heart-lung preparation.
    Abiko Y
    Fukushima J Med Sci; 1967; 14(3):95-102. PubMed ID: 4402462
    [No Abstract]   [Full Text] [Related]  

  • 8. Isoproterenol blockade in man; comparison between penbutalol and acebutolol.
    Coleman AJ; Leary WP; Asmal AC
    Curr Ther Res Clin Exp; 1974 Jan; 16(1):64-79. PubMed ID: 4149207
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiarrhythmic activity of the beta-adrenergic blocking agent 1-isopropylamino-3-(3-tolyloxy)-2-propanol (ICI 45763).
    Somani P
    Am Heart J; 1969 Jan; 77(1):63-71. PubMed ID: 5782851
    [No Abstract]   [Full Text] [Related]  

  • 10. The antiarrhythmic effects of quaternary salts of beta-adrenergic blocking agents.
    Lahiri PK; Hardman HF
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):197-211. PubMed ID: 4155279
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiarrhythmic actions of 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide (ICI 50,172) in the dog heart-lung preparation.
    Laddu AR; Somani P
    J Pharmacol Exp Ther; 1969 Nov; 170(1):79-83. PubMed ID: 4390815
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiarrhythmic potency of N-propyl ajmaline with untoward response of ventricular fibrillation in excess dose.
    Nakayama K; Koike H; Oshima T; Hashimoto K
    Jpn J Pharmacol; 1973 Feb; 23(1):9-16. PubMed ID: 4146270
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of vagus in the antagonism of ouabain induced arrhythmias in dogs by beta-adrenoceptor antagonists and related drugs.
    Alkondon M; Ray A; Sen P
    J Pharm Pharmacol; 1984 Oct; 36(10):702-4. PubMed ID: 6150094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and antiarrhythmic effects of 1-(4,5-dichloro-2-thienyl)-2-t-butylaminoethanol (QM-5119), a new beta-adrenergic blocking agent.
    Darias V; del Río J
    Arzneimittelforschung; 1974 Nov; 24(11):1756-9. PubMed ID: 4155633
    [No Abstract]   [Full Text] [Related]  

  • 15. Electrophysiologic properties of a new antiarrhythmic drug--tocainide.
    Moore EN; Spear JF; Horowitz LN; Feldman HS; Moller RA
    Am J Cardiol; 1978 Apr; 41(4):703-9. PubMed ID: 645575
    [No Abstract]   [Full Text] [Related]  

  • 16. Structure-activity relationship for antiarrhytmic actions of -receptor blocking drugs.
    Somani P; Laddu AR
    Eur J Pharmacol; 1971 May; 14(3):209-16. PubMed ID: 4405540
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective blockade of adrenoceptive beta receptors in the heart.
    Dunlop D; Shanks RG
    Br J Pharmacol Chemother; 1968 Jan; 32(1):201-18. PubMed ID: 4384337
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental cardiac arrhythmias in the evaluation of anti-arrhythmic drugs.
    Allen JD; Ekue JM; Pantridge JF; Shanks RG; Zaidi SA
    Br J Anaesth; 1971 Jul; 43(7):720-1. PubMed ID: 4398093
    [No Abstract]   [Full Text] [Related]  

  • 19. Antagonism of cardiac arrhythmias by beta-adrenoreceptor blocking agents.
    Laddu AR; Kumakura S; Somani P
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):168-81. PubMed ID: 4404932
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of action of adrenergic beta-receptor blocking agents in the prevention of cyclopropane adrenaline-evoked ventricular arrhythmias in the dog.
    Sharma PL; Narang RS
    Indian J Med Res; 1968 Aug; 56(8):1256-64. PubMed ID: 5711605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.